Medical/Pharmaceuticals
DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY
Debiopharm awards the winning scientists for the JCA (Japanese Cancer
Association) Award for innovative, disruptive, and translational oncology
research
LAUSANNE, Switzerland, Oct. 3, 2022 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023
GOTHENBURG, Sweden, Oct.1, 2022 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company's Annual General Meeting 2023 has been appointed. ...
Infinitus Products Received the Hong Kong Q-Mark Certificate
GUANGZHOU, China, Sept. 30, 2022 /PRNewswire/ -- The Q-Mark 43rd Anniversary
cum Presentation Ceremony has been successfully held at the Hong Kong
Convention and Exhibition Centre on2 September 2022. Nine Infinitus Products
Have Received the Hong Kong Q-Mark Product Certification.
YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.
* Transaction values YS Biopharma at pre-money equity value of $834 million * Certain investors ("Forward Purchase Investors") are expected to invest $30 million in a private placement concurrently with the closing of the business combination transaction pursuant to certain forward purchase ag...
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inNew Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known ...
Doxy.me extends telemedicine's reach to 88% of the world's population
Doxy.me adds over 100 languages, live interpreters, and global currencies to overcome barriers to telemedicine around the world. CHARLESTON, S.C., Sept. 30, 2022 /PRNewswire/ -- Doxy.me, the web-based telemedicine platform on a mission to make telemedicine available to all, is expanding its capa...
XSENSOR Earns the Frost & Sullivan 2022 Technology Innovation Leadership Award for Intelligent Dynamic Sensing Systems
Delivers innovative pressure measurement solutions to the world's most demanding customers. SAN ANTONIO, Sept. 29, 2022 /PRNewswire/ -- Based on its recent analysis of the sensor technology in the medical devices market,Frost & Sullivan recognizes XSENSOR Technology Corporation with the 2022 Nor...
'Generations Connect' Project Brings Young People Together with the Elderly to Boost Emotional Resilience
Engaging tailored e-platform and healthcare students promote the wellbeing of the elderly HONG KONG, Sept. 29, 2022 /PRNewswire/ -- In recent years due to the COVID-19 pandemic, elderly people have had to stay mostly at home. Confined to small living spaces for prolonged periods, many senior cit...
Manulife Hong Kong research reveals attitude shift on how Hongkongers live with COVID-19
* Hong Kong residents are trying to regain normalcy in daily lives * Mental and physical health in decline * Majority of respondents concerned about spread of another unknown disease in Hong Kong HONG KONG, Sept. 29, 2022 /PRNewswire/ -- Manulife Hong Kong today announced the results of its h...
Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution
Clinically-tested solution, based on a proprietary blend of six herbs used in
Traditional Chinese Medicine, helps relieve symptoms of acne and other skin
inflammation conditions.
TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech
Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution
Clinically-tested solution, based on a proprietary blend of six herbs used in
Traditional Chinese Medicine, helps relieve symptoms of acne and other skin
inflammation conditions.
TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech
CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION
GENEVA, Sept. 29, 2022 /PRNewswire/ -- On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate change and ai...
ASTRUM-005: The first immunotherapy clinical study of SCLC published in JAMA, one of the top medical journals in the world
* ASTRUM-005 is the first study to demonstrate that PD-1 inhibitors plus chemotherapy can improve survival for patients with ES-SCLC. * In ASTRUM-005, serplulimab combined with chemotherapy achieved by far the longest OS in first-line immunotherapy for ES-SCLC. Compared with chemotherapy, the...
ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442
First patient dosed with novel biparatopic 2+1 BEAT® bispecific antibody targeting CD38 and CD47 NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in oncology, today anno...
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment
TAMPA, Fla., Sept. 28, 2022 /PRNewswire/ -- ABILITY DIABETES-GLOBAL
Advanced Instruments Introduces Solentim VIPS™ PRO, A High Efficiency Single Cell Seeder to Optimize Cell Line Development Workflows
VIPS PRO delivers powerful and efficient seeding technology and definitive proof of monoclonality for workflow productivity and confidence. NORWOOD, Mass., Sept. 28, 2022 /PRNewswire/ -- Advanced Instruments today announced the launch ofSolentim VIPS PRO, a high efficiency single cell seeder, at...
The IND application of Biosyngen BRG01 Therapy was accepted by CDE
GUANGZHOU, China, Sept. 28, 2022 /PRNewswire/ -- The IND application of
Biosyngen BRG01 Therapy has been accepted for review by the Center for Drug
Evaluation,China (CXSL2200487)(
https://www.cde.org.cn/main/xxgk/listpage/9f9c74c73e0f8f56a8bfbc646055026d
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a base to develop the company's immunotherapy assets to address unmet needs in cancer treatment. Located in Solaris @ Tai Seng, this 1,300 square metres faci...
New GHA Certification Helps Medical Tourism Facilitators Build Patient Trust
WEST PALM BEACH, Fla., Sept. 28, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) announces the launch of a new certification program for medical travel facilitators to assist in building patient trust. GHA's Medical Travel Facilitator Certification focuses on validating the capacity ...
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased to announce a strategic drug discovery collaboration on an undisclosed target. Under the terms of the...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 318 media titles]
2024-05-20 13:48Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 314 media titles]
2024-05-21 08:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00